Medical Marijuana, Inc. (MJNA) – Company Press Releases
-
Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
-
Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
-
Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
-
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
-
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
-
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia
-
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment
-
Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President
-
Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region
-
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results
-
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil
-
GRN Holdings Corporation, Inc. (OTC: GRNF) Announces Name Change to Marijuana Inc., New Management and Business Model
-
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Health & Wellness Podcast; Secures Features in Top Brazil Lifestyle Publications
-
Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in June 2022
-
Medical Marijuana, Inc. Subsidiary HempMeds® Collaborates With Leading Research Hospital in Argentina to Study the Efficiency of CBD for Adult Epilepsy
-
Medical Marijuana, Inc. Subsidiary Kannaway Hosts Regional Conference in South Africa
-
Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in May 2022
-
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Recent Federal Court Ruling on Delta-8 THC; Launches New Hemp Products
-
Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies
-
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Feature in Forbes
-
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare CBD Safety Study
-
Medical Marijuana, Inc. Celebrates Largest Revenue Month of 2022 in April, Japan Division Achieves Best Revenue Month in History of the Company
-
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Direct Sales Veteran Eric Glenn as Entrepreneur
-
Medical Marijuana, Inc. Honored as Silver Stevie Award Winner in the 2022 American Business Awards®
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Exponential Growth; Receives Validation From Medical Community
-
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa Division in March 2022
-
Medical Marijuana, Inc. Provides Update on its Pharmaceutical Initiatives
-
Medical Marijuana, Inc. Subsidiary Kannaway® Included on New FSA List of CBD Novel Food Applicants
-
Medical Marijuana, Inc. Reports $34.1 Million in Revenue in 2021 Annual Financial and Operational Results Filing
-
Medical Marijuana, Inc. Issues New Letter to Shareholders
-
Medical Marijuana, Inc. Satisfies Major Outstanding Convertible Debt
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Leadership & Product Launch Event in Prague
-
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors First Brazilian Obesity Medicine Symposium
-
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates Best Revenue Month in Company History for South Africa and Japan Divisions in January 2022
-
Medical Marijuana, Inc. Promotes Chief Financial and Information Officer Todd Morrow to Company President
-
Medical Marijuana, Inc. Subsidiary Kannaway® Opens New Office and Warehouse in Johannesburg, South Africa
-
Medical Marijuana, Inc. Subsidiary Kannaway® Opens Distribution Center in Hong Kong
-
Medical Marijuana, Inc. Subsidiary Kannaway® Hires Jeanne Rawdin to Lead Company's Global Communications
-
Medical Marijuana, Inc. Subsidiary Kannaway® Opens New Office and Warehouse in Warsaw, Poland
-
Medical Marijuana, Inc. Subsidiary Kannaway® Celebrates New Milestone; Achieves Best Revenue Month in Company History for Japan Division in December 2021
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces November 2021 as the Best Month in Company History for Japan Division
-
Medical Marijuana, Inc. Subsidiary Kannaway Hires Jose Miguel Gutierrez Vazquez
-
Medical Marijuana, Inc. CEO Featured on Seeking Alpha’s CEO Interviews Podcast
-
Medical Marijuana, Inc. Subsidiary Kannaway® Begins Building South Africa Operations; Hires Duduzile Mathole as Country Manager
-
Medical Marijuana, Inc. Reports $9.2 Million in Net Revenue in 2021 Third Quarter Financial and Operational Results
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Promotion of Peter Dale to Global Chief Sales Officer
Back to MJNA Stock Lookup
